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Abstract: Oral infections are caused by an imbalance in the patient’s indigenous
flora which changes from commensal to opportunistic. Odontogenic infections
are the most common reason for consultation in children and adolescents. Rational
use of  antibiotics is the best strategy to avoid microbial resistance. Dental infections
should first receive proper local treatment, which can also be complemented with
a systemic method.  Appropriate drug selection and dosing should be made.
Amoxicilin is the first choice for antimicrobial agents in pediatric dentistry.
Clindamycin and clarithromycin are the best alternative for patients with penicillin
hypersensibility. In this literature review, the authors intended to establish clear
clinical management guidelines for emergency treatment and subsequent final
resolution.
Keywords: Antibiotics, microbial drug resistance, dental focal infection, children
and adolescents.
Terapias antimicrobianas en infecciones odontogénicas en
niños y adolescentes. Revisión de la literatura y recomendaciones
para la clínica.
Resumen: Las infecciones bucales son producidas por un desequilibrio de la flora
indígena del paciente que pasa de comensal a oportunista. Las consultas más
frecuentes  en niños y adolescentes son las infecciones odontogénicas. El uso
racional de antibióticos, es la estrategia más importante para evitar la resistencia
microbiana. Las infecciones dentarias deben recibir en primera instancia el tratamiento
local correspondiente y a veces complementarse con tratamiento sistémico selec-
cionando y dosificando adecuadamente el fármaco. El antimicrobiano de primera
elección en odontopediatría es la amoxicilina y para pacientes con hipersensibilidad
a las penicilinas, se indican claritromicina o clindamicina. Esta revisión de la literatura
busca establecer pautas de manejo clínico claras para el tratamiento de urgencia y
su posterior resolución definitiva.
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Introduction.
Oral infections are polymicrobial and mixed. They
arise when normal flora changes from commensal to
opportunistic due to a broken balance with the host
in certain circumstances1. The oral microbial flora starts
to grow in the newborn’s mouth about 8 hours after
birth. This is followed by a continuous change in its
composition from the time the child is edentulous until
teeth appearance2-5. (Table 1)
These oral infections can show themselves in an
acute form (acute onset, quick evolution and evident
signs and symptoms), or in a chronic form (slow onset
and evolution showing less obvious signs and
symptoms).
They are classified as odontogenic and non-
odontogenic. Odontogenic infections are the most
frequent and begin affecting peridental and dental
structures. Non- odontogenic infections start in extra
dental structures, such as mucous, glands, tongue, etc6.
These infections are usually localized and respond
well to treatment. However, favored by children’s special
features, they can spread to remote regions and cause
serious processes compromising even the patient's life.
General anatomical and physiological characteristics
of  children are varied because the age range covered
by Pediatric Dentistry is wide. For instance, the percent
of  body water and fat, as well as liver enzymes and
plasma proteins levels, are different in neonates and
infants from those of  children and adolescents.
Therefore, body size and composition, immature
gastrointestinal, renal and immune system and
nutritional status should be considered when assessing
odontopediatric patients7-8.
In the same way, jaw anatomical features also differ.
They present dental follicles, more cancellous bone
with bigger medular holes and growth sites which make
the infectious process spread quicker than in adults.
For this reason, control in children should be in a short
time. The pediatric dentist must take patient evolution
into account and pay attention to alarm signs which
may lead to hospitalization. The Consensus Document
on Antimicrobial Treatment of  Odontogenic Bacterial
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Infections9, written by specialists in microbiology and
odontology in Spain and modified for Pediatric
Dentistry (Table 2), considers these causes for
hospitalization of  a child or adolescent with
odontogenic cellulitis:
• General affectation and/or immunocompromised
patient (diabetes, malnutrit ion, HIV, etc).
• Rapidly progressive cellulitis.
• Cellulitis extending to deep facial spaces.
• Fever higher than 38°C, dyspnea and/or dysphagia
and/or severe trismus limiting mouth opening less
than 10 mm.
• Patient or family unable to comply with the
prescribed treatment.
• Failure of  initial treatment.
About 10% of  prescribed antibiotics are used for
treating oral infections6, 10-13.
Antimicrobials are indicated for therapeutic
purposes: to eliminate infection, make it less severe,
make evolution shorter and prevent general
complications. Besides, they are used for preventive
purposes in subjects with underlying diseases such as
cardiac illnesses or immunocompromised patients.
Inappropriate and irrational use of  antimicrobials
creates favorable conditions for resistant organisms to
appear, spread and persist, causing infections which
do not respond to standard treatment14.
For odontogenic infections in temporary or young
Table 2. Hospitalization criteria for pediatric patients with
odontogenic infections, modified for dentistry use from
"Consensus Statement on Antimicrobial Treatment of
Odontogenic Bacterial Infections. Bascones Martinez et al.”
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permanent dentition, local treatment is imposed. It
always includes access opening to the infected tooth
debridement with or without ducts in order to
decompress the affected area. Sometimes, it must be
supplemented with mucosal drainage if  there is a real
collection of  suppurative process. This is performed
by an incision or mucosal necrosis with trichloroacetic
acid in the largest decline. For limited to ground tooth
abscesses, for example, local procedure is usually
enough. However, if  the abscess is more diffuse
(covering neighboring areas, bottom of  vestibule or
other facial regions or affecting the patient's general
appearance), local treatment should be supplemented
with an antibiotic therapy to limit the infectious process
expansion. If  local handling is not properly done and
only antibiotics are prescribed, the virulence process
decreases. Consequently, it will become acute again
when medication is discontinued.
Once the process is reverted, it is time to decide
whether the best treatment is conservation of  the
causal tooth with proper endodontic treatment and
restoration or extraction. Just then, the urgency is
considered resolved.
Extracting the causal tooth during the emergency
while the infection is acute is absolutely contraindicated
in children and adolescents. Local treatments are
always performed with and without adjuvant
antimicrobial medication, as described, until the
infection is controlled and becomes chronic or the
process cools; the reason is to avoid producing
bacteremia through the spreading routes. When
anesthesia does not go deep in infected areas with
acid pH, it produces pain which can affect children
and adolescents’ subsequent care.
There is enough scientific evidence linking oral
infections to systemic diseases15-19.
However, although odontogenic infections are
common in children and adolescents, there are few
published works and a striking dispersion criteria in
terminology, classification and treatment guidelines9, 20.
The purpose of  this literature review is to
establish clear and updated guidelines for clinical
management, prevention and treatment of  oral
infections in this age group.
Overview.
Antibiotics era begins with the discovery of  penicillin
by Fleming in 1928. This is a substantial change for
successful infection treatment. From then on, new
types of  antimicrobial agents have constantly arisen
to control infections and overcome resistance caused
by bacteria, viruses, fungi and protozoa, and their
destructive action21. Presently, the speed at which new
multi-resistant microorganisms grow, far exceeds the
rate at which new antimicrobial substances arise. This
serious problem concerns the medical and scientific
community who fear the threat of  mankind going back
to pre-antibiotic era, making many infections untreatable.
The rapid spread of  these organisms together with the
efficiency and speed of  the current means of  transport
harm the effectiveness of  health care and security. Fast
mobility for humans and goods also enables
microorganism transportation between continents14.
Therefore, a serious updated study of  antimicrobials
is imposed for their proper use, without excesses
generating new resistance.
Rational  use of  medicines (RUM).
Among strategies to prevent microbial resistance,
one of  the most important is the rational use of
antimicrobials.
It is important for patients to receive the appropriate
medications for their clinical needs: dosing to meet
individual requirements for an adequate period of  time
at the lowest cost for them and their community14, 22.
These are other mechanisms currently used to
prevent antimicrobial resistance:
• Graduate and postgraduate medical education on
infectious diseases and evidence-based antimicrobial
prescription.
• Monitoring programs for resistant strains
emergence23.
• Rational use of  antimicrobials for animal food
production in veterinary medicine
• Cyclic rotation of  antibiotics in health institutions
(a novel concept with questionable results)21-24.
• Hospital infections control and prevention
• Increasing vaccines use21.
Choosing an antimicrobial.
It is vital to choose the correct antimicrobial and
dosage considering odontopediatric patients’
characteristics. That includes their different life stages
as well as anatomical, physiological and metabolic
characteristics, namely, size and body composition,
immature gastrointestinal, hepatic, renal and
immunological systems.
Anatomical features of  children's jaws are unique
because they present dental follicles, larger amount of
less trabeculated cancellous bone but with larger
trabeculae, highly vascularized with extensive marrow
spaces and presence of  bone growth centers7-8.  These
conditions vary as the child grows.
In this patient, health status should also be assessed
(well-constitution, any previous disease or if  he is
immunologically depressed) and the type and severity
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of  infection (mild, moderate or severe)1,25-27.
In order to arrive at the correct diagnosis and
prognosis to indicate a proper treatment plan for the
patient, a complete medical history should be
performed. It details certain information about the
patient, such as living environment, customs, health
coverage, age, family and personal background, body,
fitness, nutrit ion, general and oral health.
Additionally to patient’s characteristics, which are
very important when choosing treatment, other factors
should also be considered when prescribing
medications.
The drug, an antimicrobial agent in this case,
should be indicated in clinically justified situations
and usually as a relevant adjuvant treatment6, 12, 25.
Quality tested drugs should be used in order to ensure
that, with the correct dosage according to the severity
of  infection, the patient’s age, weight, liver and kidney
funct ion,  the result  wi l l  be as expected.
For selecting the administration via, nature and
severity of  the infection and absorptive capacity of
the drug need to be considered28. When infections
threaten the patient's life, intravenous via (IV) is
usually indicated.  Those drugs with good oral
absorption (VO) can be used in children even in
severe cases because they are very well tolerated. The
quite painful intramuscular route must be avoided in
children and adolescents whenever possible.
Considering all these elements and the infected
area (oral cavity) and flora associated with it, drug
choice is made empirically6-25.
In children and adolescents, it is necessary to
inquire about the type of  presentation, whether
pediatric tablets or solution, they commonly use.
Regardless of  age, it can happen some children take
pills and teenagers prefer a pediatric solution.
It is essential to give correct, detailed and accurate
information to the person responsible for the drug
administration.
The indicated time and frequency between takes
must be respected for successful treatment26, 29, 30.
When the presentation is in oral solution, it is
necessary to explain how to prepare, dispense and
preserve it. Emphasis should be made not to change
the dosage form by dissolving solution in juices or
opening capsules, to improve drug acceptance by the
child in all cases.
 The practitioner must observe short-term response
to treatment, especially in children, since infectious
processes spread very fast because of  their anatomical,
Table 3. Antimicrobials commonly used in pediatric dentistry. Choice and dose for patients with and without penicillin hypersensitivity.
Table 4. Comparison table for antimicrobials used in
penicillin allergic patients.
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physiological, immunological and pathological
characteristics25. The first control must be within 24
hours after the emergency consultation even by
telephone if  necessary.
Recommended length of  time must not be
excessively long because it favors the emergence of
resistance and possible side effects. Neither should it
be less than 7 days for bacteriostatics or 5 days for
bactericidals to avoid recurrence of  the infection,
forcing to repeat the treatment and favoring the
appearance of  resistance by using frequent
subtherapeutic doses1, 6, 12, 26.
Finally, the least costly alternative compared to the
same benefit and safety should be considered22.
Antimicrobials commonly used in Dentistry.
The first choice is penicillins. Among them,
Amoxicillin has bactericidal activity, good oral
absorption (75-90%)1, can be administered with food
intake and its half-life is longer than the rest31. Dosing
every 8 hours allows schedule flexibility to let the
patient sleep at night, especially when he is a child.
Moreover, the difference between therapeutic and toxic
doses is very broad, allowing a safe dosage range32, 33.
Aantimicrobial resistance (AMR) is a growing global
problem. Indiscriminate and excessive use of  penicillins
generated resistant organisms producing beta-lactamases
through mutations.
Amoxicillin, associated with irreversible beta-
lactamase inhibitors such as clavulanic acid or sulbactam
pivoxil, offers the chance to treat infections caused by
producing beta-lactamases bacteria.
This type of  associated antibiotic is the choice for
patients who have been systemically treated, but have
not received adequate local treatment (access opening
and drainage), making the infectious process to persist.
It is also indicated for subjects who do not do or do not
receive an adequate antibiotic therapy (Table 3).
Ampicillin, due to its poor oral absorption, food
intake incompatibility and dosing frequency (50 to 100
mg/kg/day every 6 hours), is preferred to be administered
parenterally.
Clindamycin (lincosamide) or clarithromycin (macrolide)
are indicated for patients with penicillin hypersensitivity
in the reviewed literature1,  12 ,  25 ,  27 (Table 4).
Clarithromycin has the advantage of a more convenient
dosing every 12 hours, generates less resistance, has good
distribution in soft tissues, and is available in pediatric
tablets and oral solution. Its disadvantage is the therapeutic
and toxic doses are very close so it should not exceed a
gram daily.
Clindamycin is taken every 6 hours and may cause
diarrhea due to Clostridium Difficile infection1. This
makes it difficult for the patient to comply with all the
indicated doses but it has good distribution in bone
tissue. Besides, it is very effective against facultative
and obligate anaerobes, thus, it is reserved for those
cases.
In some countries there is no oral solution for
clindamycin presentation which is considered a
drawback in Dentistry34-36 (Table 4).
The most important penicillin adverse effect is
hypersensitivity, which can go from a simple rash to
an anaphylactic reaction. Allergic reactions to penicillin
are described in 0.7-10 % of  exposed individuals, and
anaphylactic reactions in less than 0.004 to 0.2 %32-36.
It is contraindicated for individuals with anaphylaxis
history, urticaria or rash immediately after penicillin
administration because of the immediate hypersensitivity
risk. In such cases, neither cephalosporins or other
beta -lactam antibiotics are used as they share the basic
structure30, 34. Subjects with a minor eruption history
(not confluent and restricted to a small area of  the
body) or one occuring more than 72 hours after
penicillin administration, are possibly not allergic to it.
For these subjects, penicillin can be used for a severe
infection if  necessary.
Discussion.
Odontogenic infection is common and often leads
to widespread and severe processes. In spite of  this,
the recommended treatments are not based on scientific
evidence because the available clinical trials are difficult
to implement and very diverse. Instead, they are based
on professional agreements and consensus documents6.
Due to the special characteristics explained above,
the severity of  these infections may be higher in
children. Conducting clinical trials is more difficult in
this group; that is the reason for such few publications
on this particular population, especially in the oro-
maxillo-facial field.
This motivated a literature review to generate a
clear guideline for clinical resolution of  these processes
in pediatric dentistry.
To prescribe an antimicrobial, literature shows it is
essential to respect the characteristics of  the drug used
(time or concentration dependent), dosage form, patient
characteristics, type and severity of  infection.
These guidelines aim to rationalize the use of
antibiotics in pediatric dentistry, providing clear criteria
for treatment that minimizes antimicrobial resistance
according to the RUM current criteria.
Clinical experience shows that urgency is often the
entrance for the child or adolescent’s dental care so it
must be a positive experience. It is important to avoid
additional pain and effectively solve the patient’s
Caviglia I, Techera A & García G. Antimicrobial therapies for odontogenic infections in children and adolescents. Literature
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problem. For this reason, it is recommended to use
procedures to calm the infectious process during
emergency treatment and, later, the definitive treatment
can be done. (Table 5)
Conclusions.
Dental Infections, should first receive the appropriate
local therapy which can sometimes be complemented
with a systemic treatment. Therefore, treatment of  an
odontogenic infection is based on local or combined
(local and general) methods25.
It is vital to obtain a correct diagnosis through a
complete medical history to offer an appropriate
treatment. If  antimicrobial therapy is decided, the
professional must make the correct drug choice
according to the patient and case. Submedication should
be avoided (at a dose and/or time) as well as changes
in the dosage form to improve acceptance by the child.
There are few references in the literature to provide
information on antimicrobial use in dental origin
infections in pediatric dentistry.
Literature and clinical experience show amoxicillin
is the first choice for children. Amoxicillin associated
with sulbactam pivoxil or clavulanic acid is indicated
in patients who previously received inadequate systemic
treatment.
For patients with penicillin hypersensitivity,
clindamycin or clarithromycin are the correct choice.
Literature and clinical experience indicate it is convenient
to avoid radical procedures such as extractions at the
acute stage of  infection, taking into account the patient’s
anatomophysiological and psychological aspects
The best thing to do is to limit and cool the process
and decide the definit ive treatment then.
Correct emergency handling can change an
unpleasant situation into a valuable opportunity for
the patient and his family to be incorporated in oral
health care. This emphasizes health education,
prevention, rehabilitation and periodical checks
according to individual risk.
Considering the current concerns of  the scientific
community, it is necessary to go further with studies
promoting rational antimicrobials prescription for
children and adolescents. It is also important to support
investigation on limiting the production of multiresistant
microorganisms which compromise effective infection
control in the near future.
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